For Release: 7:00 am EST
on November 9th, 2009
Facet Solutions Enrolls 100th Patient
in US Pivotal IDE Study
Hopkinton, MA(November 9, 2009) – Facet
Solutions, Inc. today announced that it has enrolled the 100th
patient in its randomized, controlled ACADIATM IDE study for
lumbar spinal stenosis. “We are well ahead of our projections
for 2009,” stated President and CEO, Geoff Pardo, “It
is indicative of the market need, the clinical outcomes that
surgeons are seeing, and the ease with which they can implant
ACADIATM.” Over 1.5 million people are diagnosed with
lumbar spinal stenosis each year in the United States. Current
treatment alternatives include fusion, which eliminates motion
and can result in long recovery for patients.
Dr. Jim Youssef, orthopedic spine surgeon of SpineColorado
in Durango, CO, remarked, “We are excited to be a part
of this landmark study. Spinal stenosis is a common indication
that I see in my practice, and the ability to offer patients
a complete decompression while restoring motion and stability,
is a very compelling proposition for both patient and surgeon.”
Dr. Darryl DiRisio, neurosurgeon at Albany Medical
Center in Albany, NY, added, “ACADIATM is an easy to use
system that has a minimal learning curve and fits into my surgical
practice. What is exciting for these stenosis patients, in
addition to the pain relief, is the potential for a quicker
recovery over a traditional fusion.”
Facet Solutions, Inc. has developed ACADIATM to
provide patients with lumbar spinal stenosis and facet degeneration
a motion
preserving alternative to lumbar spinal fusion. The ACADIA™ procedure
includes replacement of the diseased posterior spinal joints
with an anatomic implant that is designed to restore the
natural motion, stability, and balance to the lumbar spine.
Dr. Antonio Castellvi will be presenting a worldwide clinical
update at the upcoming North American Spine Society meeting
in San Francisco, CA on November 10th at 10:15am in room 300.
About Facet Solutions
Facet Solutions, Inc. is a privately held, venture-backed
company focused on development and commercialization
of surgical devices for the treatment of degenerative
spinal disorders. Facet Solutions has received venture
capital from its partners De Novo Ventures, Spray Venture
Partners, and FirstMark Capital. Facet Solutions is certified
to ISO 13485. ACADIA™ is an investigational device
in the United States (U.S.), limited by Federal Law for
investigational use only.
# # #
Press Contact
Mr. Geoff Pardo
President & CEO
Facet Solutions, Inc.
45 South Street, Unit 1
Hopkinton, MA 01748
508-435-2492
geoff@facetsolutions.com
www.facetsolutions.com
|
